`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE DISTRICT OF DELAWARE
`
`
`BAYER HEALTHCARE LLC and BAYER
`HEALTHCARE PHARMACEUTICALS
`INC.,
`
`
`Plaintiffs,
`
`
`
`v.
`
`
`TEVA PHARMACEUTICALS USA, INC.,
`
`
`Defendant.
`
`
`
`
`
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`C.A. No. 16-1221-LPS
`
`CONSOLIDATED
`
`NOTICE OF SERVICE
`
`PLEASE TAKE NOTICE that on July 13, 2018, the following documents were served on
`
`the persons listed below in the manner indicated:
`
`1. Teva’s Supplemental Disclosures Pursuant to Paragraph 4(d) of The District of
`Delaware Default Standard for Discovery
`
`2. Defendant Teva’s Supplemental Objections and Responses to Plaintiff’s Interrogatory
`Nos. 1-3
`
`BY E-MAIL
`Jack B. Blumenfeld
`Derek J. Fahnestock
`Anthony D. Raucii
`MORRIS, NICHOLS, ARSHT & TUNNELL LLP
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`(302) 658-9200
`Jblumenfeld@mnat.com
`dfahnestock@mnat.com
`araucci@mnat.com
`
`
`
`Dov P. Grossman
`Adam L. Perlman
`Jessica Bodger Rydstrom
`Seth R. Bowers
`Ben Picozzi
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street NW
`Washington, DC 20005
`(202) 434-5000
`dgrossman@wc.com
`aperlman@wc.com
`jrydstrom@wc.com
`sbowers@wc.com
`bpicozzi@wc.com
`
`
`
`
`
`
`
`Case 1:16-cv-01221-LPS Document 68 Filed 07/16/18 Page 2 of 2 PageID #: 629
`
`
`
`/s/ Karen E. Keller
`John W. Shaw (No. 3362)
`Karen E. Keller (No. 4489)
`David M. Fry (No. 5486)
`Nathan R. Hoeschen (No. 6232)
`SHAW KELLER LLP
`I.M. Pei Building
`1105 North Market Street, 12th Floor
`Wilmington, DE 19801
`(302) 298-0700
`kkeller@shawkeller.com
`Attorneys for Defendant
`
`
`
`
`
`
`
`
`
`OF COUNSEL:
`Mark D. Schuman
`Samuel T. Lockner
`Jennell C. Bilek
`Alexandra J. Olson
`Nathan D. Louwagie
`CARLSON, CASPERS, VANDENBURGH,
` LINDQUIST & SCHUMAN, P.A.
`225 South Sixth Street
`Capella Tower, Suite 4200
`Minneapolis, MN 55402
`(612) 436-9600
`
`Dated: July 16, 2018
`
`
`
`- 2 -
`
`
`
`
`
`
`
`
`
`
`
`
`
`